NTII.US Neurobiological Technologies Inc

Healthcare Biotechnology USA Stocks
0.0001 USD
Close of Nov 15, 2026
0.0001 0.0001
Market cap
USD 2.70K
P/E
-
P/B
0.07x
ROE
321.0%
Dividend yield
930,322.10%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2010.

Is NTII.US undervalued?

Graham number

The Graham number of Neurobiological Technologies Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Neurobiological Technologies Inc fundamental analysis

No fundamental analysis for Neurobiological Technologies Inc yet.

Neurobiological Technologies Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Neurobiological Technologies Inc

Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. Previously, it focused on developing investigational drugs for the treatment of human diseases. The company was founded in 1987 and is based in Emeryville, California.

Full company profile